Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 3 studies | 20% ± 2% |
Insufficient scRNA-seq data for expression of BCKDHA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 2025.66 | 966 / 966 | 28% | 0.82 | 147 / 527 |
stomach | 100% | 3107.69 | 359 / 359 | 19% | 0.47 | 53 / 286 |
bladder | 100% | 2318.05 | 21 / 21 | 16% | 0.43 | 81 / 504 |
uterus | 100% | 2215.44 | 170 / 170 | 3% | 0.06 | 16 / 459 |
ovary | 99% | 2299.20 | 178 / 180 | 4% | 0.07 | 19 / 430 |
adrenal gland | 100% | 6452.32 | 258 / 258 | 3% | 0.04 | 7 / 230 |
kidney | 100% | 3148.56 | 89 / 89 | 2% | 0.03 | 21 / 901 |
pancreas | 100% | 2096.02 | 328 / 328 | 2% | 0.02 | 3 / 178 |
prostate | 100% | 2331.41 | 245 / 245 | 2% | 0.02 | 8 / 502 |
liver | 100% | 4033.51 | 226 / 226 | 1% | 0.02 | 5 / 406 |
lung | 98% | 2282.73 | 568 / 578 | 3% | 0.04 | 34 / 1155 |
breast | 100% | 2669.58 | 459 / 459 | 1% | 0.01 | 12 / 1118 |
thymus | 100% | 3511.56 | 653 / 653 | 1% | 0.01 | 6 / 605 |
esophagus | 100% | 3240.44 | 1442 / 1445 | 1% | 0.01 | 2 / 183 |
adipose | 100% | 2453.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 5220.59 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2420.59 | 241 / 241 | 0% | 0 | 0 / 0 |
skin | 100% | 2862.34 | 1807 / 1809 | 0% | 0 | 0 / 472 |
blood vessel | 100% | 1953.25 | 1331 / 1335 | 0% | 0 | 0 / 0 |
brain | 98% | 1769.16 | 2601 / 2642 | 1% | 0.01 | 6 / 705 |
peripheral blood | 98% | 2888.73 | 914 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 3553.72 | 842 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.13 | 4 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009083 | Biological process | branched-chain amino acid catabolic process |
GO_0160157 | Cellular component | branched-chain alpha-ketoacid dehydrogenase complex |
GO_0045252 | Cellular component | oxoglutarate dehydrogenase complex |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0047101 | Molecular function | branched-chain alpha-keto acid dehydrogenase activity |
GO_0003863 | Molecular function | 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity |
GO_0016831 | Molecular function | carboxy-lyase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | BCKDHA |
Protein name | 2-oxoisovalerate dehydrogenase subunit alpha (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) Branched chain keto acid dehydrogenase E1 subunit alpha 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha) |
Synonyms | |
Description | FUNCTION: Together with BCKDHB forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA which is subsequently utilized to produce energy. The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid forming an enzyme-product intermediate. A reductive acylation mediated by the lipoylamide cofactor of E2 extracts the acyl group from the E1 active site for the next step of the reaction. . FUNCTION: Together with BCKDHB forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA which is subsequently utilized to produce energy. The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid forming an enzyme-product intermediate. A reductive acylation mediated by the lipoylamide cofactor of E2 extracts the acyl group from the E1 active site for the next step of the reaction. . FUNCTION: Together with BCKDHB forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA which is subsequently utilized to produce energy. The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid forming an enzyme-product intermediate. A reductive acylation mediated by the lipoylamide cofactor of E2 extracts the acyl group from the E1 active site for the next step of the reaction. . FUNCTION: Together with BCKDHB forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA which is subsequently utilized to produce energy. The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid forming an enzyme-product intermediate. A reductive acylation mediated by the lipoylamide cofactor of E2 extracts the acyl group from the E1 active site for the next step of the reaction. . FUNCTION: Together with BCKDHB forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA which is subsequently utilized to produce energy. The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid forming an enzyme-product intermediate. A reductive acylation mediated by the lipoylamide cofactor of E2 extracts the acyl group from the E1 active site for the next step of the reaction. . |
Accessions | A0A0M5IJ90 ENST00000269980.7 [P12694-1] ENST00000541315.1 P12694 F5GXU9 H0YH31 H0YH20 ENST00000544905.1 A0A0M4C4P8 ENST00000542943.5 ENST00000457836.6 [P12694-2] |